Quadripolar Leads for the Management of Heart Failure Patients in the Middle East
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 389 participants.
Also called NCT02195843
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking
- Phase
- Phase 4
- Enrolled
- 389 participants
- Registry
-
NCT02195843
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02195843. Randomized; no masking. Start 2014-08 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Quadripolar Leads for the Management of Heart Failure Patients in the Middle East
- Acronym
- QUADRA-ME
- Condition
- Heart Failure
- Intervention (Other)
- Electrical optimization by RVLV Conduction Time with VectSelect
- Intervention (Other)
- Anatomical optimization of device and leads
- Intervention (Device)
- Implanted device and lead (Cardiac Resynchronization Therapy Defibrillator (CRT-D) device and SJM Quadripolar lead system)
- Lead sponsor
- King Abdullah International Medical Research Center
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02195843- Content hash
8a80dd2e4e7235e5410b6aadf64dec8c293a2fb715d699b9c770f35a7c90eb7c